BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6444969)

  • 21. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB
    Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T; Tanino T; Egawa K
    Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1986 Feb; 136(3):837-43. PubMed ID: 3079800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression and abrogation of suppression of induced nonspecific cytotoxicity against tumor cells.
    Egawa K; Tanino T
    Jpn J Exp Med; 1985 Aug; 55(4):143-53. PubMed ID: 2935654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor cells in spleens of mice with low natural killer activity.
    Blair PB; Staskawicz MO; Sam JS
    J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
    Santoni A; Santoni G; Piccoli M; Herberman RB; Frati L
    Immunopharmacol Immunotoxicol; 1990; 12(3):363-87. PubMed ID: 2148342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation.
    Remick DG; Kunkel SL; Higashi GI; Hiserodt JC
    J Immunol; 1988 Apr; 140(7):2225-30. PubMed ID: 3127462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
    Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P
    Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
    J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells.
    Bartlett SP; Burton RC
    J Immunol; 1982 Mar; 128(3):1070-5. PubMed ID: 7057032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.